The study, conducted by researchers with the Centers for Disease Control and Prevention (CDC), found that six bacterial ...

Medical honey proves effective against antibiotic-resistant bacteria, transforming wound care and offering hope in the fight ...

Recent worldwide emergence of CA-MRSA has prompted the development of several new antibiotics (see Table 2). In the past, as vancomycin became less effective against MRSA, clinicians turned to ...

MRSA was once eradicated reliably by vancomycin (Vancocin AE), an antibiotic of the glycopeptide class. With time, the MRSA bacteria became resistant to vancomycin and vancomycin-resistant ...

Increased VISA growth in diabetic infection Vancomycin is frequently used to treat MRSA-associated bacteremia. Infection with vancomycin intermediate-resistance S. aureus (VISA) strains are three ...

Its R&D pipeline includes antibiotic product candidates that target Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin ...

Ten projects at Queen’s are receiving support from the Canadian Institutes of Health Research to advance research that will have a high impact on health care knowledge and delivery.

Acurx Pharmaceuticals, Inc. ("we" or "Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, today ...